🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Franziska Michor

Dana-Farber Cancer Institute

ORCID: 0000-0003-4869-8842
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

(2024)10.1158/1078-0432.c.7181344.v1
Top 100%
0DataRank
Top 100%0 citations

Jiexin Zhang, Dzifa Y. Duose, Edgar Gonzalez‐Kozlova, Mary W. Redman, Hong Chen +42 more

Papers

Driven by 13 papers — median percentile 0. Top paper: “Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer”.

Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer

Nature Communications(2021)10.1038/s41467-021-23912-4
N/A
1.1DataRank · unranked
34 citations

Adam J. Schoenfeld, Alex Makhnin, Yosef Y. Tobi, Yuli Wang, Heidie Frisco Cabanos +10 more

Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-0251
N/A
0.564DataRank · unranked
42 citations

Jiexin Zhang, Dzifa Y. Duose, Edgar Gonzalez‐Kozlova, Mary W. Redman, Hong Chen +42 more

H3K36 methylation maintains cell identity by regulating opposing lineage programmes

Nature Cell Biology(2023)10.1038/s41556-023-01191-z
N/A
0.564DataRank · unranked
42 citations

Masaki Yagi, Bruno Di Stefano, Justin Langerman, Simona Cristea, Lai Ping Wong +10 more

Computational modelling of perivascular-niche dynamics for the optimization of treatment schedules for glioblastoma

Nature Biomedical Engineering(2021)10.1038/s41551-021-00710-3
N/A
0.533DataRank · unranked
34 citations

Hans‐Georg Wirsching, Jamie Dean, Yu-Kang Cheng, Samuel Emerson, Siobhan S. Pattwell +3 more

Reconstruction of single-cell lineage trajectories and identification of diversity in fates during the epithelial-to-mesenchymal transition

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2406842121
N/A
0.464DataRank · unranked
21 citations

Yun Zhang, Shubham Tripathi, B. V. Harshavardhan, Mohit Kumar Jolly, Geoffrey Schiebinger +4 more

Reconstructing the lineage histories and differentiation trajectories of individual cancer cells in JAK2 -mutant myeloproliferative neoplasms

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.08.24.265058
N/A
0.241DataRank · unranked
4 citations

Javier Escabi, Maximilian Nguyen, Shichen Liu, Christopher R. Reilly, Sachin Patel +16 more

Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR -Mutant Lung Adenocarcinomas

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3484
N/A
0.165DataRank · unranked
2 citations

Alex Makhnin, Khadeja A. Moses, Linda S. Ahn, Isabel R. Preeshagul, Afsheen N. Iqbal +9 more

Mathematical Modeling Identifies Optimum Palbociclib-fulvestrant Dose Administration Schedules for the Treatment of Patients with Estrogen Receptor–positive Breast Cancer

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0257
N/A
0DataRank · unranked
11 citations

Shayna Stein, Agostina Nardone, Weihan Liu, Wen Ma, Gabriella Cohen +5 more

A paracrine circuit of IL-1β/IL-1R1 between myeloid and tumor cells drives genotype-dependent glioblastoma progression

Journal of Clinical Investigation(2023)10.1172/jci163802
N/A
0DataRank · unranked
66 citations

Bruno Giotti, Milota Kaluzová, Montse Puigdelloses Vallcorba, Kavita Rawat, Gabrielle A. Price +18 more

Data from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

(2024)10.1158/1078-0432.c.7181344.v1
Top 100%
0DataRank
Top 100%0 citations

Jiexin Zhang, Dzifa Y. Duose, Edgar Gonzalez‐Kozlova, Mary W. Redman, Hong Chen +42 more

BESTDR Enables Bayesian Quantification of Mechanism-Specific Drug Responses

Cancer Research(2025)10.1158/0008-5472.can-25-1181
N/A
0DataRank · unranked
0 citations

Simone Bruno, James P. Roney, Ioannis K. Zervantonakis, Franziska Michor, Thomas O. McDonald

Imaging dynamic mTORC1 pathway activity in vivo reveals marked shifts that support time-specific inhibitor therapy in AML

Nature Communications(2021)10.1038/s41467-020-20491-8
N/A
0DataRank · unranked
38 citations

François Mercier, Hiroki Kato, Yookyung Jung, Thomas O. McDonald, Joel A. Spencer +7 more

Topological isolation of developmental regulators in mammalian genomes

Nature Communications(2021)10.1038/s41467-021-24951-7
N/A
0DataRank · unranked
35 citations

Alexandro Landshammer, Elena K. Stamenova, Adriano Bolondi, Helene Kretzmer, Alexander Meissner +2 more